Research Article

Astragaloside Inhibits Hepatic Fibrosis by Modulation of TGF-β1/Smad Signaling Pathway

Figure 6

Effects of astragalosides on MDA, GSH, and SOD in liver tissues. (a) The content of malondialdehyde (MDA) was measured by thiobarbituric acid method; AST was found to increase the level of MDA. (b) The content of glutathione (GSH) was detected by spectrophotometry, and superoxide dismutase (SOD) was detected by xanthine oxidase method (c). AST was found to decrease GSH and SOD levels. AST: astragalosides; LY-364947: TGF-β receptor 1 inhibitor. The values presented are the means ± SD ( in each group). and versus control group; and versus model group (CCL4).
(a)
(b)
(c)